Advm Stock Predictions

Healthcare > Biotechnology

Buy ADVM

*Your capital is at risk

$4.36

+0 (+0%)

At Close: Mar 06, 2026

Currently predicting for Fri, 5 Jun 2026

ADVM Prediction Chart

ADVM Predictions History

Latest community submissions for ADVM.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
NameNotImportant Pro	May 6, 2019	$6.83 -89.82%	$6.71	X	98.21%
GoldenNugget Pro	May 6, 2019	$6.50 -90.31%	$6.71	X	96.92%
NameNotImportant Pro	May 3, 2019	$6.27 -90.54%	$6.63	V	94.57%
NameNotImportant Pro	May 2, 2019	$6.69 -89.66%	$6.47	X	96.60%
NameNotImportant Pro	Apr 24, 2019	$5.82 -91.21%	$6.62	V	87.92%
JS Pro	May 11, 2018	$5.65 -90.34%	$5.85	V	96.60%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ADVM with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ADVM

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with U...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	4.43%	Jun 01
N NVRI $19.53	0.87%	May 20
RUN $12.83	15.51%	May 06
GLBE $31.61	4.05%	May 05
SAP $172.39	8.56%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by